Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study
<p>Abstract</p> <p>Background</p> <p>Genetic variations in the calpain-10 gene (<it>CAPN10</it>), in particular the at-risk diplotype (112/121), were previously implicated with increased risk of type 2 diabetes (T2D).</p> <p>Methods</p> <...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
BMC,
2010-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_724a80f4c68149f2a4b1e7312bf1ba0a | ||
042 | |a dc | ||
100 | 1 | 0 | |a Mahjoub Touhami |e author |
700 | 1 | 0 | |a Al-Khateeb Ghada M |e author |
700 | 1 | 0 | |a Kacem Maha |e author |
700 | 1 | 0 | |a Chaieb Molka |e author |
700 | 1 | 0 | |a Messaoudi Safia |e author |
700 | 1 | 0 | |a Turki Amira |e author |
700 | 1 | 0 | |a Ezzidi Intissar |e author |
700 | 1 | 0 | |a Almawi Wassim Y |e author |
700 | 1 | 0 | |a Mtiraoui Nabil |e author |
245 | 0 | 0 | |a Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study |
260 | |b BMC, |c 2010-05-01T00:00:00Z. | ||
500 | |a 10.1186/1471-2350-11-75 | ||
500 | |a 1471-2350 | ||
520 | |a <p>Abstract</p> <p>Background</p> <p>Genetic variations in the calpain-10 gene (<it>CAPN10</it>), in particular the at-risk diplotype (112/121), were previously implicated with increased risk of type 2 diabetes (T2D).</p> <p>Methods</p> <p>We examined the association of <it>CAPN10 </it>UCSNP-43 (rs3792267), UCSNP-19 (rs3842570), and UCSNP-63 (rs5030952) SNPs with T2D in 917 Tunisian T2D patients and 748 non-diabetic controls. <it>CAPN10 </it>genotyping was done by PCR-RFLP.</p> <p>Results</p> <p>Enrichment of UCSNP-19 2R (minor) allele and 2R/2R genotype was found in T2D patients; the allele and genotype distribution of UCSNP-43 and UCSNP-63 alleles and genotypes were not significantly different between patient groups and non-diabetic control subjects. Regression analysis demonstrated progressive increases in T2D risk in 3R/2R [OR (95% CI) = 1.35 (1.08 - 1.68)] and 2R/2R [OR (95% CI) = 1.61 (1.20 - 2.18)] genotypes. Of the six haplotypes detected, enrichment of haplotype 111 (UCSNP-43/UCSNP-19/UCSNP-63) was seen in patients (<it>Pc </it>= 0.034); the distribution of the other haplotypes was comparable between patients and control subjects; neither haplotype 211 nor haplotype 212 was observed. Furthermore, the frequency of all <it>CAPN10 </it>diplotypes identified, including the "high-risk diplotype (112/121) reported for Mexican-Americans and Northern Europeans, were comparable between patients and controls.</p> <p>Conclusions</p> <p><it>CAPN10 </it>UCSNP-19 variant, and the 111 haplotype contribute to the risk of T2D in Tunisian subjects; no significant associations between <it>CAPN10 </it>diplotypes and T2D were demonstrated for Tunisians.</p> | ||
546 | |a EN | ||
690 | |a Internal medicine | ||
690 | |a RC31-1245 | ||
690 | |a Genetics | ||
690 | |a QH426-470 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n BMC Medical Genetics, Vol 11, Iss 1, p 75 (2010) | |
787 | 0 | |n http://www.biomedcentral.com/1471-2350/11/75 | |
787 | 0 | |n https://doaj.org/toc/1471-2350 | |
856 | 4 | 1 | |u https://doaj.org/article/724a80f4c68149f2a4b1e7312bf1ba0a |z Connect to this object online. |